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Introduction
Bronchial provocation is often used to diagnose asthma or monitor disease control. Dyspnea perception, however, associates poorly with the induced drop in 
FEV1. Some subjects perceive dyspnea well before the drop, while others perceive non. This discrepancy may arise from the origin of dyspnea. As a provocation 
test solely uses the large airways parameter FEV1, although dyspnea is associated with both large- and small airways dysfunction. 
Aims
We explored if induced dyspnea perception is equal for nebulized adenosine 5’-monophosphate (AMP) and dry powder adenosine, targeting large and small 
airways, respectively. Further we investigated if dyspnea perception associates better with large or small airways dysfunction.
Methods
For this study, we used the baseline data of the previously published OLiVIA study1, in which asthmatics performed an AMP and an adenosine provocation.
All 59 subjects performed spirometry, impulse oscillometry (IOS), and Borg dyspnea score, of whom 36 completed a multiple breath nitrogen washout (MBNW). 
Spearman’s correlation analysis was used to associate the change(Δ) in Borg score to the change in large and small airways parameters. To construct a linear 
multivariate regression model a large and a small airways parameter2 was selected (lowest p-value) from spirometry and IOS. MBNW was analyzed separately.
Results 
• Provocation with adenosine and AMP evoked a decreases in FEV1 of 23.4±8% and 21.1±8%, respectively.
  This corresponded with similar levels of induced dyspnea (Figure 1). ΔBorg did not associated with ΔFEV1 for neither adenosine nor AMP provocation. 
• ΔBorg after adenosine provocation associated with a decrease in FEF25 (p=0.01), FEF75 (p<0.01), and FEF25-75 (p<0.01, Figure 2) 
     and in the multivariate linear regression model (Table 2a) a decrease in FEF25-75 was independently associated with an increase in Borg. 
• ΔBorg after AMP provocation associated univariately with an increased AX (p=0.05) and a decreased X5 (p=0.04, Figure 3), 
     but in the multivariate analyses no independent associations were found between ΔBorg and any large or small airways parameters (Table 2b).
Conclusions 
• AMP and adenosine induce equally severe dyspnea perception.
• Dry powder adenosine-induced dyspnea seems related to small airways involvement independent of the large airways.
• AMP-induced dyspnea associates with neither large nor small airways dysfunction.
• Our results may indicate that dry powder adenosine and nebulized AMP induce dyspnea via different processes.
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Table 1: Baseline characteristics
          count or median (IQR)
Gender (M-F)      24 - 35
Age (years)       47.0 (37.0; 55.0)
Smoking (Current-Ex)    30 - 29
Pack-years (years)      16.8 (11.0; 26.0)
Adenosine provocation (mg) 3.11 (0.87; 6.38)
AMP provocation (mg mL-1)   14.67 (4.7; 44.88)
FEV1 (%pred)      85 (74; 96)
FVC (%pred)      105 (94; 116)
FEV1/FVC (%)      70 (62; 77)
FEF25-75(%pred)     49 (35; 65)
R5(kPa sL-1)      0.53 (0.42; 0.67)
R20 (kPa sL-1)      0.42 (0.35; 0.47)
AX (kPa L-1)      0.64 (0.24; 1.82)
X5(kPa sL-1)             -0.13 (-0.22; -0.09)
LCI5%        6.22 (5.76; 7.37)
Scond        0.04 (0.02; 0.06)
Sacin         0.14 (0.10; 0.19)
Table 2: Multivariate models for ΔBorg
   All subjects        MBNW 
        subgroup
A. Adenosine
    B (p-value)   B (p-value)
Gender    -0.83 (0.37)   -0.81 (0.37)
Smoking status    0.32 (0.65)    0.45 (0.51)
Δ FEV1(L)      1.50 (0.43)    0.98 (0.60)
Δ FEF25-75 (Ls-1)   -2.18 (0.04)   -1.82 (0.09)
Δ R20 (kPa sL-1)   -8.28 (0.11)   -6.53 (0.20)
Δ R5-R20 (kPa sL-1) 2.61 (0.27)    3.20 (0.18)
Δ Scond     14.56 (0.16)
B. AMP
    B (p-value)   B (p-value)
Gender   0.25 (0.78)   0.55 (0.62)
Smoking status -0.11 (0.90)  -0.23 (0.81)
Δ FEV1(L)  -0.97 (0.62)  -0.74 (0.72)
Δ FEF50 (Ls-1)  0.50 (0.54)   0.60 (0.48)
Δ R20 (kPa sL-1) -2.00 (0.76)  -1.01 (0.88)
Δ X5 (kPa sL-1) -0.64 (0.67)  -0.69 (0.65)
Δ LCI5%       0.22 (0.65)
AMP and adenosine induced dyspnea perception 
associated to large and small airways dysfunction in asthma
Figure 1: Changes in Borg score (ΔBorg) 
from pre-provocation to post-provocation for 
adenosine and AMP. Both agents increase 
dyspnea perception to the same degree.
Figure 2: Correlation of change(Δ) in Borg and FEF25-75. 
Adenosine(♦) induced ΔBorg correlates with ΔFEF25-75, while 
AMP(●) induced ΔBorg lacks a correlation.
Figure 3: Correlation of change(Δ) in Borg and X5 
AMP(●) induced ΔBorg correlates with ΔX5, while adenosine(♦) 
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